Researchers say the ability to visualize health data in three dimensions can unlock patterns and relationships among predictive biomarkers that conventional data visualization can’t convey. That’s why Zeeshan Ahmed and his team at Rutgers developed 3D IntelliGenes, an advanced artificial intelligence and machine-learning platform with the ability to visually analyze multiple types of biological and clinical data—known as multiomics.
AI platform uses 3D visualization to reveal disease biomarkers in multiomics data
-
HighlightsFree Dark Web Monitoring Stamps the $17 Million Credentials Markets
-
HighlightsSmart buildings: What happens to our free will when tech makes choices for us?
-
AppsScreenshots have generated new forms of storytelling, from Twitter fan fiction to desktop film
-
HighlightsDarknet markets generate millions in revenue selling stolen personal data, supply chain study finds
-
SecurityPrivacy violations undermine the trustworthiness of the Tim Hortons brand
-
Featured HeadlinesWhy Tesla’s Autopilot crashes spurred the feds to investigate driver-assist technologies – and what that means for the future of self-driving cars
